Literature DB >> 8403397

Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations.

G Eggertsen1, R Tegelman, S Ericsson, B Angelin, L Berglund.   

Abstract

We analyzed blood samples from 407 healthy Swedish individuals, 244 men and 163 women, ages 17 to 86 years, for apolipoprotein (apo) E isoforms and serum triglycerides, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and total cholesterol. Parallel genotyping by means of polymerase chain reaction (PCR)-amplified DNA was performed in 200 subjects. Identical results were obtained by genotyping and phenotyping in 95% of all subjects analyzed. The apo E allelic frequencies were 7.8% for epsilon 2, 71.9% for epsilon 3, and 20.3% for epsilon 4. Compared with other Caucasian populations, the present population had a high relative allelic frequency of epsilon 4. The epsilon 4 frequency decreased with increasing age and was significantly lower in individuals > 60 years of age (14.7%). When controlling for age and sex, there were strong correlations between total serum and LDL cholesterol and the various epsilon alleles. The epsilon 4 and epsilon 3 alleles correlated positively with serum cholesterol and the epsilon 4 allele correlated positively with LDL cholesterol. In contrast, HDL cholesterol and serum triglycerides did not show any correlation to the allele types. Thus, the results demonstrate a considerable age variation of the epsilon allele frequency among healthy Swedes and an influence of apo E alleles on serum and LDL cholesterol concentrations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403397

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  24 in total

Review 1.  Genetic epidemiology in aging research.

Authors:  M Daniele Fallin; Amy Matteini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-23       Impact factor: 6.053

2.  Genotype-environment interaction: apolipoprotein E (ApoE) gene effects and age as an index of time and spatial context in the human.

Authors:  K E Zerba; R E Ferrell; C F Sing
Journal:  Genetics       Date:  1996-05       Impact factor: 4.562

3.  N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions.

Authors:  A L Hubbard; D J Harrison; C Moyes; A H Wyllie; C Cunningham; E Mannion; C A Smith
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

Review 4.  Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.

Authors:  R Katzman; D Kang; R Thomas
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 5.  The vascular contribution to Alzheimer's disease.

Authors:  Robin Altman; John C Rutledge
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

6.  Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.

Authors:  Neena Theresa Kumar; Knut Liestøl; Else Marit Løberg; Henrik Mikael Reims; Jan Mæhlen
Journal:  Virchows Arch       Date:  2015-04-22       Impact factor: 4.064

7.  Apolipoprotein E (APOE) and warfarin dosing in an Italian population.

Authors:  Hugo Kohnke; Maria Gabriella Scordo; Vittorio Pengo; Roberto Padrini; Mia Wadelius
Journal:  Eur J Clin Pharmacol       Date:  2005-08-26       Impact factor: 2.953

8.  Warfarin dose related to apolipoprotein E (APOE) genotype.

Authors:  Hugo Kohnke; Kristina Sörlin; Göran Granath; Mia Wadelius
Journal:  Eur J Clin Pharmacol       Date:  2005-06-11       Impact factor: 2.953

9.  Parental longevity and diabetes risk in the Diabetes Prevention Program.

Authors:  Hermes Florez; Yong Ma; Jill P Crandall; Leigh Perreault; Santica M Marcovina; George A Bray; Christopher D Saudek; Elizabeth Barrett-Connor; William C Knowler
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-08-17       Impact factor: 6.053

10.  No change of the lipid profile under the control of ApoE gene polymorphism in schizophrenics under paliperidone treatment.

Authors:  Wei-Tsung Kao; Chen-Lin Chang; Yi-Lung Chen; For-Wey Lung
Journal:  Psychiatr Q       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.